**Core Concept**
The patient's presentation of recurrent lower backache, history of chest infections, iritis, conjunctivitis, HLA-B27 positivity, and elevated inflammatory markers is suggestive of ankylosing spondylitis (AS), a type of spondyloarthritis. AS is characterized by chronic inflammation of the axial skeleton and peripheral joints, leading to pain, stiffness, and eventual fusion of the spine.

**Why the Correct Answer is Right**
The pathogenesis of ankylosing spondylitis involves an abnormal immune response, with a key role played by interleukin-23 (IL-23). IL-23 promotes the differentiation of Th17 cells, which are involved in the production of pro-inflammatory cytokines and the activation of autoreactive T cells, leading to inflammation and tissue damage in AS. The patient's HLA-B27 positivity is a genetic predisposition that increases the risk of developing AS, but it is not the primary driver of the disease process.

**Why Each Wrong Option is Incorrect**
**Option A:** Interleukin-1 (IL-1) is involved in the inflammatory response, but it is not the primary interleukin involved in the pathogenesis of ankylosing spondylitis.
**Option B:** Interleukin-4 (IL-4) is involved in the regulation of the immune response, particularly in the differentiation of Th2 cells, but it is not directly involved in the pathogenesis of AS.
**Option C:** Interleukin-10 (IL-10) is an anti-inflammatory cytokine that regulates the immune response, but it is not the primary interleukin involved in the pathogenesis of AS.

**Clinical Pearl / High-Yield Fact**
Ankylosing spondylitis is a classic example of a spondyloarthritis, which is characterized by inflammation of the axial skeleton and peripheral joints. The disease is strongly associated with HLA-B27 positivity, but the exact pathogenesis is complex and involves multiple genetic and environmental factors.

**Correct Answer: C. Interleukin-23 (IL-23) is most commonly involved in the pathogenesis of ankylosing spondylitis.